Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2009 Dec;32(12):2307-13.
doi: 10.2337/dc09-0615.

Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis

Tien Y Wong  1 , Mkaya Mwamburi, Ronald Klein, Michael Larsen, Harry Flynn, Marisol Hernandez-Medina, Gayatri Ranganathan, Barbara Wirostko, Andreas Pleil, Paul Mitchell
Affiliations
Meta-Analysis

Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis

Tien Y Wong et al. Diabetes Care. 2009 Dec.

Abstract

Objective: This meta-analysis reviews rates of progression of diabetic retinopathy to proliferative diabetic retinopathy (PDR) and/or severe visual loss (SVL) and temporal trends.

Research design and methods: This systematic literature review and meta-analysis of prospective studies assesses progression of retinopathy among diabetic patients without treatment for retinopathy at baseline. Studies published between 1975 to February 2008 were identified. Outcomes of interest were rates of progression to PDR and/or SVL. Pooled baseline characteristics and outcome measures were summarized using weighted averages of counts and means. Baseline characteristics and outcomes were compared between two periods: 1975-1985 and 1986-2008.

Results: A total of 28 studies comprising 27,120 diabetic patients (mean age 49.8 years) were included. After 4 years, pooled incidence rates for PDR and SVL were 11.0 and 7.2%, respectively. Rates were lower among participants in 1986-2008 than in 1975-1985. After 10 years, similar patterns were observed. Participants in 1986-2008 studies had lower proportions of PDR and non-PDR at all time points than participants in 1975-1985 studies.

Conclusions: Since 1985, diabetic patients have lower rates of progression to PDR and SVL. These findings may reflect an increased awareness of retinopathy risk factors; earlier identification and initiation of care for patients with retinopathy; and improved medical management of glucose, blood pressure, and serum lipids. Differences in baseline characteristics, particularly in the prevalence and severity of retinopathy, could also have contributed to these temporal differences.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Selection of studies for systematic review.
See this image and copyright information in PMC

References

    1. Congdon NG, Friedman DS, Lietman T: Important causes of visual impairment in the world today. JAMA 2003; 290: 2057– 2060 - PubMed
    1. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 2003; 290: 1884– 1890 - PubMed
    1. Ciulla TA, Amador AG, Zinman B: Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes Care 2003; 26: 2653– 2664 - PubMed
    1. Marshall SM, Flyvbjerg A: Prevention and early detection of vascular complications of diabetes. BMJ 2006; 333: 475– 480 - PMC - PubMed
    1. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994; 330: 15– 18 - PubMed

Publication types